Literature DB >> 22862685

Anesthetic considerations for rapid-onset obesity, hypoventilation, hypothalamic dysfunction, and autonomic dysfunction (ROHHAD) syndrome in children.

Arvind Chandrakantan1, Thomas J Poulton.   

Abstract

Rapid-onset obesity, hypoventilation, hypothalamic dysfunction, and autonomic dysfunction is an increasingly common diagnosis in patients who are being seen at tertiary care children's hospitals. We present two cases of anesthetics from the authors' own experience in addition to a comprehensive review of the disorder and anesthetic implications.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22862685     DOI: 10.1111/j.1460-9592.2012.03924.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  5 in total

Review 1.  Genetic and Syndromic Causes of Obesity and its Management.

Authors:  Ildiko H Koves; Christian Roth
Journal:  Indian J Pediatr       Date:  2017-11-27       Impact factor: 1.967

2.  Central Hypoventilation Syndromes.

Authors:  Christopher Cielo; Carole L Marcus
Journal:  Sleep Med Clin       Date:  2014-03-01

3.  Peri-operative management of a child with ROHHAD-NET syndrome undergoing neural crest tumour excision.

Authors:  S Puri; S Yaddanapudi; P Menon
Journal:  Anaesth Rep       Date:  2022-06-17

4.  Rapid-Onset Obesity with Hypoventilation, Hypothalamic, Autonomic Dysregulation, and Neuroendocrine Tumors (ROHHADNET) Syndrome: A Systematic Review.

Authors:  Jiwon M Lee; Jaewon Shin; Sol Kim; Heon Yung Gee; Joon Suk Lee; Do Hyeon Cha; John Hoon Rim; Se-Jin Park; Ji Hong Kim; Ahmet Uçar; Andreas Kronbichler; Keum Hwa Lee; Jae Il Shin
Journal:  Biomed Res Int       Date:  2018-11-21       Impact factor: 3.411

5.  Case Report: Considerations of nocturnal ventilator support in ROHHAD syndrome in chronic care of childhood central hypoventilation with hypothalamus dysfunction.

Authors:  Rui Zhao; Xiaosong Dong; Zhancheng Gao; Fang Han
Journal:  Front Pediatr       Date:  2022-08-31       Impact factor: 3.569

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.